135 related articles for article (PubMed ID: 11478906)
1. Differential roles of developmentally distinct SNAP-25 isoforms in the neurotransmitter release process.
Puffer EB; Lomneth RB; Sarkar HK; Singh BR
Biochemistry; 2001 Aug; 40(31):9374-8. PubMed ID: 11478906
[TBL] [Abstract][Full Text] [Related]
2. SNAP-25a and -25b isoforms are both expressed in insulin-secreting cells and can function in insulin secretion.
Gonelle-Gispert C; Halban PA; Niemann H; Palmer M; Catsicas S; Sadoul K
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):159-65. PubMed ID: 10085240
[TBL] [Abstract][Full Text] [Related]
3. Differential contribution of syntaxin 1 and SNAP-25 to secretion in noradrenergic and adrenergic chromaffin cells.
Baltazar G; Tomé A; Carvalho AP; Duarte EP
Eur J Cell Biol; 2000 Dec; 79(12):883-91. PubMed ID: 11152280
[TBL] [Abstract][Full Text] [Related]
4. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
5. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
Lawrence GW; Foran P; Dolly JO
Eur J Biochem; 1996 Mar; 236(3):877-86. PubMed ID: 8665909
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
Apland JP; Adler M; Oyler GA
J Protein Chem; 2003 Feb; 22(2):147-53. PubMed ID: 12760419
[TBL] [Abstract][Full Text] [Related]
7. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity of catecholamine release to botulinum toxin C1 and E suggests selective targeting of vesicles set into the readily releasable pool.
Stigliani S; Raiteri L; Fassio A; Bonanno G
J Neurochem; 2003 Apr; 85(2):409-21. PubMed ID: 12675917
[TBL] [Abstract][Full Text] [Related]
9. Phospholipaise A2 and arachidonic acid-mediated mechanism of neuroexocytosis: a possible target of botidinum neurotoxin A other then SNAP-25.
Ray P; Ishida H; Millard CB; Petrali JP; Ray R
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S27-8. PubMed ID: 10594896
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
11. SNAP-25 is required for a late postdocking step in Ca2+-dependent exocytosis.
Banerjee A; Kowalchyk JA; DasGupta BR; Martin TF
J Biol Chem; 1996 Aug; 271(34):20227-30. PubMed ID: 8702751
[TBL] [Abstract][Full Text] [Related]
12. Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro.
Lawrence GW; Wang J; Brin MF; Aoki KR; Wheeler L; Dolly JO
FEBS J; 2014 Jul; 281(14):3243-60. PubMed ID: 24863955
[TBL] [Abstract][Full Text] [Related]
13. Differential distribution and regulation of expression of synaptosomal-associated protein of 25 kDa isoforms in the Xenopus pituitary gland and brain.
Kolk SM; Groffen AJ; Tuinhof R; Ouwens DT; Cools AR; Jenks BG; Verhage M; Roubos EW
Neuroscience; 2004; 128(3):531-43. PubMed ID: 15381282
[TBL] [Abstract][Full Text] [Related]
14. A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.
Bajohrs M; Rickman C; Binz T; Davletov B
EMBO Rep; 2004 Nov; 5(11):1090-5. PubMed ID: 15486565
[TBL] [Abstract][Full Text] [Related]
15. Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-L1 adipocytes and cleaves cellubrevin unlike type A toxin which failed to proteolyze the SNAP-23 present.
Chen F; Foran P; Shone CC; Foster KA; Melling J; Dolly JO
Biochemistry; 1997 May; 36(19):5719-28. PubMed ID: 9153412
[TBL] [Abstract][Full Text] [Related]
16. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
Keller JE; Neale EA
J Biol Chem; 2001 Apr; 276(16):13476-82. PubMed ID: 11278807
[TBL] [Abstract][Full Text] [Related]
17. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons.
Foran PG; Mohammed N; Lisk GO; Nagwaney S; Lawrence GW; Johnson E; Smith L; Aoki KR; Dolly JO
J Biol Chem; 2003 Jan; 278(2):1363-71. PubMed ID: 12381720
[TBL] [Abstract][Full Text] [Related]
19. A discontinuous SNAP-25 C-terminal coil supports exocytosis.
Chen YA; Scales SJ; Jagath JR; Scheller RH
J Biol Chem; 2001 Jul; 276(30):28503-8. PubMed ID: 11373287
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of SNAP-25 family proteins in the mouse brain.
Yamamori S; Itakura M; Sugaya D; Katsumata O; Sakagami H; Takahashi M
J Comp Neurol; 2011 Apr; 519(5):916-32. PubMed ID: 21280044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
